The Chemours Newsroom

Chemours Is Maintained at Equal-Weight by Barclays

Dow JonesSep 25 23:50

Chemours Analyst Ratings

BenzingaSep 25 23:40

巴克莱银行维持The Chemours(CC.US)持有评级，下调目标价至21美元

Futu NewsSep 25 17:33

Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $23

Futu NewsSep 4 00:31

Morgan Stanley Maintains The Chemours(CC.US) With Hold Rating, Maintains Target Price $30

Futu NewsAug 6 21:33

Barclays Maintains Equal-Weight on Chemours, Lowers Price Target to $22

BenzingaAug 6 21:13

Chemours Analyst Ratings

BenzingaAug 6 19:55

BMO Capital Maintains The Chemours(CC.US) With Buy Rating, Cuts Target Price to $30

Futu NewsAug 6 19:34

Barclays Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $22

Futu NewsAug 6 18:31

Chemours Analyst Ratings

BenzingaJul 9 20:57

UBS Upgrades Chemours to Buy From Neutral, Raises Price Target to $30 From $28

MT NewswiresJul 9 20:18

Chemours Analyst Ratings

BenzingaJun 7 18:45

Barclays Keeps Their Hold Rating on Chemours Company (CC)

TipRanksMay 15 17:35

Chemours Upgraded at BMO Capital After Internal Audit Completed

Seeking AlphaApr 9 19:42

Bank of Montreal, Canada: The Chemours (CC.US) rating was raised, and the target price was adjusted from $19.00 to $34.00, from unanimous market to superior market rating.

Zhitong FinanceApr 9 17:51

Chemours Analyst Ratings

BenzingaApr 9 17:50

BMO Capital Upgrades Chemours to Outperform, Raises Price Target to $34

BenzingaApr 9 17:50

Chemours Analyst Ratings

BenzingaApr 3 02:15

UBS Adjusts Chemours Price Target to $28 From $21, Maintains Neutral Rating

MT NewswiresApr 2 22:44

Research Alert: CFRA

MT NewswiresApr 2 02:18